For the more expensive trials yes, I think they will still try to use a partner to fund them. However, if we do end up selling Novel for around 10 million, we will have a lot of powder left over since these BE trials don't cost near as much as a full phase 3 trial would. I'm kind of curious about this.

I mean, with 10 million, we have around 6.7 million left after FULLY paying off all debt, and if we partner for Phase 3 we don't have to worry about that 3-5 million for that study. So subtract...another million or so for other trials and we still have 5 million left or so. That's a nice piece of change.